Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02257528
Title Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

cervical squamous cell carcinoma

cervical adenocarcinoma

cervical adenosquamous carcinoma

Therapies

Nivolumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.